Myofascial pain syndrome

From WikiMD's WELLNESSPEDIA


Myofascial pain syndrome
Synonyms MPS
Pronounce N/A
Specialty N/A
Symptoms Muscle pain, tenderness, stiffness, trigger points
Complications Chronic pain, sleep disturbances, depression
Onset Any age, more common in adults
Duration Can be chronic
Types N/A
Causes Muscle overuse, stress, injury
Risks Poor posture, stress, sedentary lifestyle
Diagnosis Physical examination, patient history, trigger point identification
Differential diagnosis Fibromyalgia, tension headache, arthritis
Prevention N/A
Treatment Physical therapy, trigger point injection, medication, massage therapy
Medication NSAIDs, muscle relaxants, antidepressants
Prognosis N/A
Frequency Common
Deaths N/A


Myofascial Pain Syndrome (MPS) is a chronic pain disorder characterized by muscle pain and tenderness. The pain is typically associated with specific trigger points within the muscles, which can cause referred pain in seemingly unrelated parts of the body. MPS is a common condition that can affect any muscle group and is often associated with musculoskeletal disorders.

Symptoms[edit]

The primary symptom of Myofascial Pain Syndrome is deep, aching muscle pain. Other symptoms may include:

  • Muscle stiffness
  • Limited range of motion in affected muscles
  • Pain that worsens with activity or stress
  • Presence of trigger points that are tender to touch
  • Referred pain patterns

Causes[edit]

The exact cause of Myofascial Pain Syndrome is not fully understood, but several factors may contribute to its development, including:

Diagnosis[edit]

Diagnosis of Myofascial Pain Syndrome is primarily clinical and involves a thorough medical history and physical examination. Key diagnostic criteria include:

  • Identification of trigger points
  • Reproduction of pain upon palpation of trigger points
  • Exclusion of other conditions that may cause similar symptoms

Treatment[edit]

Treatment for Myofascial Pain Syndrome often involves a combination of therapies, including:

Prognosis[edit]

The prognosis for individuals with Myofascial Pain Syndrome varies. With appropriate treatment, many people experience significant relief from symptoms. However, some individuals may have chronic symptoms that require ongoing management.

Related Pages[edit]

Template:ChronicPain-stub


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.